UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 475

Sortiert nach

Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo

Annals of oncology, 2020-09, Vol.31 (9), p.1216-1222

2020

Volltextzugriff (PDF)

A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study

Annals of oncology, 2019-08, Vol.30 (8), p.1279-1288

2019

Volltextzugriff (PDF)

α-Smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 study

British journal of cancer, 2014-11, Vol.111 (10), p.1917-1923

2014

Volltextzugriff (PDF)

SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study

Annals of oncology, 2014-05, Vol.25 (5), p.1025-1032

2014

Volltextzugriff (PDF)

Reconstructing tumor history in breast cancer: signatures of mutational processes and response to neoadjuvant chemotherapy

Annals of oncology, 2021-04, Vol.32 (4), p.500-511

2021

Volltextzugriff (PDF)

Human equilibrative nucleoside transporter 1 expression analysed by the clone SP 120 rabbit antibody is not predictive in patients with pancreatic cancer treated with adjuvant gemcitabine – Results from the CONKO-001 trial

European journal of cancer (1990), 2015-08, Vol.51 (12), p.1546-1554

2015

Volltextzugriff (PDF)

Expression of secreted protein acidic and rich in cysteine (SPARC) in breast cancer and response to neoadjuvant chemotherapy

Annals of oncology, 2015-01, Vol.26 (1), p.95-100

2015

Volltextzugriff (PDF)

A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer

Annals of oncology, 2018-01, Vol.29 (1), p.162-169

2018

Volltextzugriff (PDF)

Evaluation of Mucin-1 protein and mRNA expression as prognostic and predictive markers after neoadjuvant chemotherapy for breast cancer

Annals of oncology, 2013-09, Vol.24 (9), p.2316-2324

2013

Volltextzugriff (PDF)

RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapy

Annals of oncology, 2013-03, Vol.24 (3), p.632-639

2013

Volltextzugriff (PDF)

SPARC expression in resected pancreatic cancer patients treated with Gemcitabine: results from the CONKO-001 study

Annals of oncology, 2017-11, Vol.28 (11), p.2900-2900

2017

Volltextzugriff (PDF)

Final analysis of the Male-GBG54 study: A prospective, randomised multi-centre phase II study evaluating endocrine treatment with either tamoxifen +/- gonadotropin releasing hormone analogue (GnRHa) or an aromatase inhibitor + GnRHa in male breast cancer patients

Annals of oncology, 2018-10, Vol.29, p.viii706-viii706

2018

Volltextzugriff (PDF)

Effects of Bacteriophages on the Population Dynamics of Four Strains of Pelagic Marine Bacteria

Microbial ecology, 2001-10, Vol.42 (3), p.395-406

2001

Volltextzugriff (PDF)

Processing and high strain rate impact response of multi-functional sandwich composites

Composite structures, 2001-05, Vol.52 (3), p.429-440

2001

Volltextzugriff (PDF)

Precise measurement of protein interacting fractions with fluorescence lifetime imaging microscopy

Molecular bioSystems, 2011-02, Vol.7 (2), p.322-336

2011

Volltextzugriff (PDF)

177P TP53 and PRBM1 mutations predict “hot” tumor microenvironment in intrahepatic cholangiocarcinoima

Annals of oncology, 2021-12, Vol.32, p.S1460

2021

Volltextzugriff (PDF)

Ancient Polyploidy and Genome Evolution in Palms

Genome biology and evolution, 2019-05, Vol.11 (5), p.1501-1511

2019

Volltextzugriff (PDF)

Corrections to “SPARC expression in resected pancreatic cancer patients treated with Gemcitabine: results from the CONKO-001 study”

Annals of oncology, 2017-11, Vol.28 (11), p.2900-2900

2017

Volltextzugriff (PDF)

Phylogenomics, biogeography and evolution in the American genus Brahea (Arecaceae)

Botanical journal of the Linnean Society, 2019-06, Vol.190 (3), p.242-259

2019

Volltextzugriff (PDF)

17P Impact of body mass index (BMI) on prognostic and predictive value of stromal tumour-infiltrating lymphocytes (sTILs) in triple-negative breast cancer (TNBC): A pooled analysis of six neoadjuvant trials

Annals of oncology, 2021-05, Vol.32, p.S27-S28

2021

Volltextzugriff (PDF)

28P EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy

Annals of oncology, 2021-05, Vol.32, p.S32

2021

Volltextzugriff (PDF)

21P BACH1 and HIF1α predict response to neoadjuvant nab-paclitaxel (nP) treatment in early breast cancer (BC)

Annals of oncology, 2021-05, Vol.32, p.S29

2021

Volltextzugriff (PDF)

TP53 mutation predicts sensitivity to adjuvant gemcitabine in pancreatic cancer: Results from the CONKO-001 study

Annals of oncology, 2017-09, Vol.28, p.v251-v251

2017

Volltextzugriff (PDF)

Abstract P1-17-07: Cancer management and outcome of very young non-pregnant patients with breast cancer diagnosed at 40 years or younger– GBG 29

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P1-P1-17-07

2019

Volltextzugriff (PDF)

1 – 25 von 475

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(413)
Mit Volltextzugriff
(422)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo

A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study

α-Smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 study

SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study

Reconstructing tumor history in breast cancer: signatures of mutational processes and response to neoadjuvant chemotherapy

Human equilibrative nucleoside transporter 1 expression analysed by the clone SP 120 rabbit antibody is not predictive in patients with pancreatic cancer treated with adjuvant gemcitabine – Results from the CONKO-001 trial

Expression of secreted protein acidic and rich in cysteine (SPARC) in breast cancer and response to neoadjuvant chemotherapy

A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer

Evaluation of Mucin-1 protein and mRNA expression as prognostic and predictive markers after neoadjuvant chemotherapy for breast cancer

RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapy

SPARC expression in resected pancreatic cancer patients treated with Gemcitabine: results from the CONKO-001 study

Final analysis of the Male-GBG54 study: A prospective, randomised multi-centre phase II study evaluating endocrine treatment with either tamoxifen +/- gonadotropin releasing hormone analogue (GnRHa) or an aromatase inhibitor + GnRHa in male breast cancer patients

Effects of Bacteriophages on the Population Dynamics of Four Strains of Pelagic Marine Bacteria

Processing and high strain rate impact response of multi-functional sandwich composites

Precise measurement of protein interacting fractions with fluorescence lifetime imaging microscopy

177P TP53 and PRBM1 mutations predict “hot” tumor microenvironment in intrahepatic cholangiocarcinoima

Corrigendum to “A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study”: [Annals of Oncology (2019), volume 30:1279-1288]

Ancient Polyploidy and Genome Evolution in Palms

Corrections to “SPARC expression in resected pancreatic cancer patients treated with Gemcitabine: results from the CONKO-001 study”

Phylogenomics, biogeography and evolution in the American genus Brahea (Arecaceae)

17P Impact of body mass index (BMI) on prognostic and predictive value of stromal tumour-infiltrating lymphocytes (sTILs) in triple-negative breast cancer (TNBC): A pooled analysis of six neoadjuvant trials

28P EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy

21P BACH1 and HIF1α predict response to neoadjuvant nab-paclitaxel (nP) treatment in early breast cancer (BC)

TP53 mutation predicts sensitivity to adjuvant gemcitabine in pancreatic cancer: Results from the CONKO-001 study

Abstract P1-17-07: Cancer management and outcome of very young non-pregnant patients with breast cancer diagnosed at 40 years or younger– GBG 29

Suchergebnisse filtern